Study of epigenetic changes and chromatin structural modifications associated with hematopoietic cancers, leukemias and lymphomas

The team analyzes the effects of epigenetic changes and chromatin structural modifications associated with hematopoietic cancers, leukemias and lymphomas.

Our clinical collaborations include the Hematology Unit at Necker Hospital in Paris (T-cell Leukemias) and several National Hospitals and Research Centers: H. Mondor (Créteil), Inst. Curie (Paris), Necker Hospital (Paris), IGR (Villejuif), CHU Purpan (Toulouse), CHU V. Segalen (Bordeaux), as well as the Assistance Publique-Hôpitaux de Marseille (AP-HM) and the Myeloid Leukemias team of the Institut Paoli-Calmettes (Marseille).

This project is supported by Inserm (Interface Contract); the Association pour la Recherche sur le Cancer (ARC), the Fondation de France (comité leucémie), the Fondation Laurette Fugain, the Fondation pour la Recherche Médicale (FRM), the Foundation Princesse Grace de Monaco and the Institut National du Cancer ((Lymphomas/Network; INCa PAIR Lymphome).